This review compares the effects of various sexually transmitted disease (STD) partner-noti® cation strategies. Using review methods endorsed by the Cochrane Collaboration, it updates previous reviews, and addresses some of their methodological limitations. It includes 11 randomized controlled trials (RCTs) comparing two or more strategies, including 8014 participants. Only two trials were conducted in developing countries, and only two trials were conducted among HIV-positive patients. The review found moderately strong evidence that: (1) provider referral alone, or the choice between patient and provider referral, when compared with patient referral among patients with HIV or any STD, increases the rate of partners presenting for medical evaluation; (2) contract referral, when compared with patient referral among patients with gonorrhoea, results in more partners presenting for medical evaluation; (3) verbal, nurse-given health education together with patient-centred counselling by lay workers, when compared with standard care among patients with any STD, results in small increases in the rate of partners treated. The review concludes that there is a need for evaluations of interventions combining provider training and patient education, for evaluations conducted in developing countries, and for the measurement of potential harmful effects.
INTRODUCTION
Partner noti® cation is a process whereby the sex partners of patients diagnosed with an STD (index patients) are informed of their exposure to infection and thus the need to visit a health service. It aims to prevent reinfection of the index patient, a clinical goal, and reduce the spread of STDs, a public health goal. Three approaches to partner noti® cation have been used:
. Provider referral uses third parties (usually health service personnel) to notify partners.
. Patient referral occurs when health service personnel encourage index patients to notify their partners. . Contract referral (or conditional referral) refers to when health service personnel encourage index patients to notify their partners, with the understanding that health service personnel will notify those partners who do not visit the health service by an agreed date.
To succeed, partner noti® cation strategies need to ® rst elicit from the index patient details of all sex partners from whom he/she may have acquired the infection, or whom he/she might have subsequently infected. Identifying partners in the latent period of infection (usually three months for primary syphilis and one month for most others 1 ) will usually identify those from whom infection was acquired, while identifying partners after the onset of symptoms will identify those who may have been infected by the index case. Partner noti® cation has been practised for decades, with substantial resources directed towards it, and with little evidence as to whether it has made a public health impact on disease transmission. Most of the evaluations were not randomized controlled trials, and were conducted in the United States, prior to the HIV/AIDS epidemic. There are reasons to question whether partner noti® cation for gonorrhoea and chlamydia is applicable to HIV. It is also questionable whether interventions for the developed world are applicable to the developing world.
Two systematic reviews have been conducted prior to our review. The ® rst included only studies conducted in developed countries 2 . It included 12 controlled studies and concluded that there was strong evidence that simple forms of patient assistance, directed at improving patient referral (such as referral cards and reminder telephone calls), were effective in increasing the number of partners presenting for care, and there was moderately strong evidence that, for HIV, provider referral results in more partners being noti® ed than patient referral. The effects of provider referral for other STDs were not clear. There was weak evidence that specially trained interviewers were more effective than routine health care providers at identifying partners, but there was no evidence that this resulted in improved noti® cation or treatment. There was no evidence of the potential harms of provider referral.
The second, more recent review included only published studies conducted after 1980 in the USA 3 . It reviewed 13 comparative or cohort studies and found that partner noti® cation detected 0.03± 0.24 infections of syphilis, gonorrhoea, chlamydia or HIV in partners, per index patient, and 0.7± 11% of noti® ed partners were infected. It concluded, based on the results of randomized and nonrandomized studies, that provider referral, when compared with patient referral, results in more partners being noti® ed and medically evaluated. It provided no evidence of the comparative effects of different methods of patient referral.
Both the previous reviews had limitations in their methods of analysis. The ® rst assumed that the number of partners noti® ed (or treated) per index patient followed a binomial distribution (which assumes a ® xed number of partners per patient) 2 . This does not ® t the reality, where index patients have variable numbers of partners, and can thus only be considered a crude approximation. The second review did not include any statistical inference on intervention effects 3 .
The objectives of this review are to compare provider referral with contract and patient referral, and to compare different patient referral strategies to each other. In addition to up-dating previous reviews, we have expanded the scope to address partner noti® cation in developing countries as well as in developed countries, with particular consideration for partner noti® cation for HIV/AIDS, and we have attempted to address some of the methodological limitations of earlier reviews.
METHODS
We included published or unpublished randomized controlled trials (RCTs) comparing two or more alternative partner noti® cation strategies for people diagnosed with STDs, and which measured any of the following outcomes: partners elicited (named or counted by index patient), located, noti® ed, medically evaluated (including partners presented for care at a health service, tested positive, and/or treated), harms to the index patient or partner (such as domestic violence, abuse or suicide), index patient reinfection rates, incidence of STDs, or changes in index patient's or partner's behaviour. We included costs (adjusted for in¯ation to 2001 values based on the consumer price index) of partner noti® cation strategies when these were available.
We searched MEDLINE, EMBASE, Psychological Abstracts, Sociological Abstracts, and the Cochrane Controlled Trials register using an algorithm based on the Cochrane standard search for trials, and the keywords`sexual partners',`partner noti® cation', and`contact tracing'. We hand-searched the Proceedings of the International AIDS Conferences from 1994 to 2000, and the International Society for STD Research meetings (ISSTDR) from 1991 to 1999. In addition, experts in the ® eld were contacted to identify studies, and references in all studies were scanned for additional trials.
For each of the included RCTs, the following criteria of methodological quality were independently assessed by two reviewers: Whether randomization was designed and completed in an appropriate manner; whether the participation rate was greater than 80%; whether participants were analysed in the groups to which they were assigned; whether outcome assessors were blinded to the assignment status of the participants; whether the groups were similar at the start of the trial; and whether the groups were treated equally in all aspects other than the intervention.
ANALYSIS
For each study we tabulated the rate of partners elicited, noti® ed, presenting for care, tested, treated or harmed, per index patient in the respective comparison groups (see Table 1 ). We assumed that the index patients from all groups within a study had similar distributions for exposure time to partners, for time to notify their partners, and that the same assumption held for partners with respect to the time taken to present to the health service. Thus, we assumed that the number of units counted (partners elicited, noti® ed, presenting for care, tested, treated or harmed) per index patient was a random variable following a Poisson distribution. To calculate a con® dence interval for the difference in the rate of partners elicited, noti® ed, etc, we used the normal approximation to the Poisson distribution, since only summarized data from the included RCTs were available. In studies where the rate of partners elicited per index patient was not reported, the number of contact cards given to the index patient was used as a proxy indicator. Where the rate reduction was signi® cant, the numbers needed to treat (NNT) were calculated. The NNT refers to the number of index patients that would need to receive the intervention for one additional partner to be elicited, to be noti® ed, to present for medical evaluation, etc.
RESULTS
We found 11 RCTs, including 8014 participants. Most trials were conducted in the USA (USA 8, South Africa 1, Zambia 1, Denmark 1). Eight trials were based in public health services, one was conducted at a university, one in private practice and one completely outside formal health services, in a converted storefront. Table 1 describes the trials, their participants, the interventions, and the outcome measures. Seven trials compared patient, provider or contract strategies. Seven trials compared various patient referral strategies, including ® nancial incentives for the index patient, reminder telephone calls to the index patient, a video-based health education intervention, other health education and counselling strategies, alternative ways of testing partners for chlamydial infection, and the use of various health workers. Two trials measured harms; the rate of quarrels between the index patient and partners 4 and suicide and domestic violence 5 . Patient preferences were only measured in one study 5 . Table 1 also describes the methodological quality of the included studies, and shows that there is some risk of bias in all of the included trials. Randomization was adequately concealed in only two trials 4, 5 . One of these is still underway and only preliminary results are available 5 , and the other relied on a method of assessing outcomes that had a substantial risk of bias 4 : index patients' reports of whether they noti® ed their partners and whether their partners presented for care. Outcomes were assessed blindly in only one trial 6 . Data on baseline comparability of the intervention and comparison groups were provided in only three studies 4, 6, 7 and in one other study these data were obtained by writing to the author 8 . The participation rate (proportion of those eligible who participated in the research) was reported to be greater than 80% in ® ve trials 4,5± 9 .
Gonorrhoea, chlamydia and non-gonococcal urethritis
Among patients with gonorrhoea, chlamydia or non-gonococcal urethritis (NGU), there was one comparison of provider versus patient referral, two comparisons of contract versus patient referral, and ® ve comparisons of alternative patient referral strategies. There were no trials comparing provider and contract referral or testing alternative strategies to improve either provider or contract referral. Table 1 describes the results of the studies comparing the relative effectiveness of provider, contract and patient referral strategies. In two studies of patients with NGU and gonorrhoea respectively 10, 11 , patients receiving the patient referral interventions elicited signi® cantly more partners than those receiving provider or contract referral interventions. In the ® rst study, 2.8 (95% CI=1.8 to 5.9) index patients would need to be offered patient referral, compared with provider referral, for one extra partner to be elicited 10 . In the second study, 2.5 (95% CI=1.7 to 4.8) index patients would need to be offered patient referral, compared with contract referral, for one extra partner to be elicited 11 . In a third study, contract and patient referral were equally effective at eliciting partners 12 .
In the three above-mentioned trials, patient referral strategies were consistently less effective at ensuring partners received medical evaluation than either provider or contract referral strategies. In the trial conducted among patients with NGU 10 , provider referral was compared to either of two patient referral strategies Ð in one, patients were counselled by nurses and, in the other, patients were counselled by disease interventions specialists (DISs), who are professionals trained in partner noti® cation. Provider referral (using DISs not only to elicit names, but to contact the partners), compared to either of the patient referral strategies, resulted in more partners receiving treatment (0.7 compared with 0.2 per index patient). Two index patients would need to be offered provider referral for one extra partner to receive treatment 10 . This is despite the patient referral strategies resulting in the elicitation of more partners.
Provider referral also resulted in a greater chlamydial isolation rate among elicited partners (0.09 compared with 0.03 per index patient; NNT=16.7 [95% CI= 9.1 to 100]). A limitation in this study was that the effectiveness of the patient referral strategies may have been considerably underestimated due to bias in outcome-assessment: partners choosing to be treated at other health services were not counted in the patient referral groups, while they were counted in the provider referral group. The cost of provider referral per partner treated was $85 as compared to $18 (nurse as provider) and $158 (DIS as provider) for patient referral. The cost of provider referral per partner with a positive culture was $675 as compared to $120 (nurse provider) and $845 (DIS provider) for patient referral. The incremental cost of having one additional partner treated was $113 for provider referral versus patient referral (nurse-given education), and $60 for provider referral versus patient referral (DIS-given education).
The two trials conducted among patients with gonorrhoea comparing contract with patient referral found that contract referral was more effective at ensuring partners received medical evaluation 11, 12 . The ® rst of these trials compared contract referral with two alternate patient referral strategies and found that contract referral resulted in more partners presenting for care (0.62 compared with 0.37 per index patient; NNT=4 [95% CI=3 to 5.9] in both comparisons) and more partners testing positive (0.37 compared with 0.24; NNT=7.7 [95% CI=5.3 to 14.3] in the ® rst comparison; and 0.37 compared with 0.25; NNT=8.3 [95% CI=5.6 to 16.7] in the second) 11 . This is despite the fact that patient referral was more effective at eliciting partners. Contract referral was more than three times as costly per infected partner treated than either of the patient referral strategies. In¯ation-adjusted costs could not be calculated as the year in which the study was done was not reported.
The other trial among patients with gonorrhoea found a non-signi® cant trend for more partners to present to health services with contract referral: 1.27 compared with 1.15 per index patient 12 . No cost information was reported. Table 1 also describes the results of the studies comparing the effects of various patient referral strategies. One study of patients with NGU 10 found that patient referral with nurse-given health education, and with no identifying details of partners taken, when compared with patient referral with a disease intervention specialist who took names of partners, resulted in more partners being elicited (1.2 compared with 0.8 per index patient). Approximately two index patients would need to be offered the nurse-given intervention for one extra partner to be elicited (NNT=2.4; 95% CI=1.7 to 4.4). There was, however, no signi® cant difference between the two strategies in the numbers of partners who tested positive or were treated. The strategy with nurse-given health education cost only $4 per patient counselled, versus $28 per patient counselled for the DIS strategy. The nurse-given strategy yielded a few more partners treated, and, importantly, when compared with the DIS strategy, resulted in a savings of $608 per extra partner treated.
Three studies compared various patient referral strategies among patients with gonorrhoea. They compared health education using an educational pamphlet with standard care 11 , an educational video with standard care 13 , and counselling and reminder telephone calls with counselling and modest ® nancial incentives ($3 in 1990) for the index patient and partner 9 . None of these studies found signi® cant differences in the number of partners elicited or receiving medical evaluation or treatment. Due to methodological weaknesses in two of the studies 9,13 , there is insuf® cient evidence to draw ® rm conclusions regarding the effects of educational videos and reminder telephone calls compared with incentives. The study evaluating the educational video counted returned contact cards as the main outcome 13 , which may not be a sensitive surrogate indicator for partners presenting for care.
In another trial included in this review, Potterat et al. showed that contact card returns constituted a poor proxy indicator for partners receiving medical evaluation 12 . Of 198 named partners, 54% sought medical evaluation, yet if the investigators had relied on card returns, they would have concluded that only 7% had sought medical evaluation (only one of the other trials included in this review relied on returned contact cards as an indicator of partner treatment) 6 . The study comparing reminder telephone calls with incentives included only 38 participants 9 , and there was no indication that they had conducted a sample size determination prior to performing the study (indeed, of all the studies included in this review, only two provided details of sample-size determinations 6,7 ). Furthermore, university students with sex partners outside of the university campus were excluded from the study, this perhaps limiting the generalizability of the results.
Comparisons of the costs included in two of these studies found that the cost per partner identi® ed with a positive culture was the same for health education using an educational pamphlet and standard care 11 , and that incentives were more than three times the cost per partner contacted than reminder telephone calls ($17 versus $5 when physicians were used to do the counselling; $14 versus $3 when nurses were used to do the counselling) 9 .
A small study, conducted among women with chlamydia attending private practices in Denmark, compared two strategies for testing male partners for chlamydia 8 . In the ® rst strategy, female index patients gave their partners an envelope containing a sterile container, and information about collecting a urine sample at home and sending it in a prepaid envelope to the laboratory for testing. In the second strategy, female index patients gave their partners an envelope containing a request for them to visit a doctor, a contact slip and a prepaid envelope to give to the doctor for returning the urethral swab sample to the laboratory. The urine test strategy increased the number of partners who had a specimen tested for chlamydia by the laboratory (0.98 compared with 0.37 per index patient in the urethral swab test strategy). Approximately two index patients would need to receive the intervention (urine test) for one extra partner to send a specimen for testing (NNT=1.6; 95% CI=1.1 to 3.6). There was, however, no difference in the number of specimens that tested positive. Neither was there a difference between strategies in the number of partners elicited. The authors of this study were not able to determine whether more partners in the intervention group were eventually treated, thus the practical bene® ts of such an intervention are as yet unknown.
Syphilis
In people with syphilis, one large trial including 1966 participants compared two forms of provider referral with each other, and with contract referral 7 . The relative effectiveness of the strategies is presented in Table 1 . Patients receiving provider referral with ® eld testing (the health worker who noti® es the partner has the option of drawing blood in the ® eld if the partner seems unlikely to come to the clinic for a syphilis test) elicited more partners than those receiving the contract referral intervention (NNT=2; 95% CI=1.3 to 4.8). Contract referral was more effective at eliciting partners than provider referral without ® eld testing (NNT=70.46; 95% CI=70.51 to 70.41). However, despite these differences in the rate of partner elicitation, no signi® cant differences between the three strategies were found in the rate of partners located, tested, testing positive and treated. There was little difference in the costs of the interventions, which ranged from $290± $315 per partner tested, and $396± $452 per partner treated. The investigators reported some evidence of`contamination', in that some of those assigned to the contract referral group received one of the provider referral interventions. Furthermore, they speculated that there had been subversion of the randomization schedule. These problems may explain the absence of an effect. However, aside from these problems, the three strategies being tested were not very different (for example, with the contract referral, index patients were only given two days before the disease intervention specialists sought their partners).
Among people with syphilis, we found no trials comparing strategies to improve patient or contract referral. Nor did we ® nd trials comparing provider or contract referral with patient referral.
HIV
Among people with HIV, only two comparisons were reviewed. The relative effectiveness of the alternate strategies is presented in Table 1. In the ® rst trial it was found that offering index patients a choice between provider or patient referral, compared with patient referral alone, resulted in more partners being noti® ed (2.0 per index patient compared with 0.3 per index patient; NNT=0.6; 95% CI=0.5 to 0.7) 14 . In the group with the choice, most partners (70, 89.7%) were noti® ed by the provider, and only eight by the index patient. More partners in the group with the choice tested HIVpositive: 0.23 compared with 0.03 per index patient; NNT=5; 95% CI=2.7 to 25. There was no difference between strategies in the number of partners elicited. The participation rate in this study was 46%, and the participants re¯ected a select group of HIV-positive patients who, when compared with those declining to participate, and those ineligible or unavailable, were more likely to be female, black and to have been tested con® dentially rather than anonymously. The male participants were more likely to be homosexual or bisexual.
The second study among HIV-positive index patients compared a choice between provider and patient referral, with patient referral alone 5 . This trial was underway at the time of the review and did not have results on the relative effectiveness of the alternate strategies. The investigators had, however, reported patient preferences with regard to provider and patient referral. The provider referral strategy involved the use of indigenous community workers to notify those partners the index patient did not want to notify themselves. The identity of the index patient was not revealed to the partners. Both patient and provider referral strategies included community-based testing for partners. Among the group of index patients randomly allocated to receive a choice between provider and patient referral, provider referral was preferred, with 82% of patients choosing provider referral for at least one partner. Of all the partners elicited by index patients in this group, 71% were noti® ed by the indigenous community workers as a result of the index patients' preferences.
We found no trials comparing alternate strategies to improve patient referral, contract referral or provider referral among people with HIV. Nor did we ® nd studies comparing provider referral with contract referral, or contract referral with patient referral.
Any STD
Among people with any STD, two trials were reviewed, both conducted in developing countries. In the ® rst, conducted in Zambia, offering index patients a choice between provider and patient referral, counselling (10± 20 minutes) and contact cards, was compared with patient referral without counselling or contact cards 4 . The second trial was conducted in South Africa and evaluated three strategies to improve patient referral 6 . Health education, counselling, and a combination of health education and counselling were compared with standard care. The results of these comparisons are included in Table 1 .
The Zambian trial found that offering male index patients a choice between provider and patient referral as well as counselling and contact cards, resulted in index patients reporting that more partners had been noti® ed (1.8 partners per index patient were noti® ed in the group with the counselling and cards, compared with 1.3 in the patient referral group without counselling and cards) 4 . The choice between provider and patient referral, counselling and contact cards would need to be offered to two index patients (95% CI=1.3 to 4.8) for one extra partner to be noti® ed. It also resulted in index patients reporting that more partners presented at a health service for care (1.8 compared with 1.2 per index patient; NNT=1.7; 95% CI= 1.2 to 3.1). However, the index patients' reports were not validated in any way, so these differences may re¯ect a reporting bias. It is not possible to know which part of the intervention (providing a choice between provider and patient referral, counselling, or contact cards) was responsible for the increase in reported partners presenting for care. Among female index patients, there were no differences between the comparison groups. When comparing the harms resulting from the respective strategies, a higher rate of domestic quarrels was reported among men in the group with a choice between patient or provider referral, counselling and cards, compared with those in the patient referral group. No differences with regard to quarrels were detected among women index patients.
The South African trial evaluated the effects of three strategies to improve standard patient referral: nurse-given health education, patientcentred counselling by lay workers, and a combination of these two strategies 6 . Patients in the group given health education, and those in the group given both health education and the 20± 30 minute counselling session, elicited more partners than those in the control (standard care) group (1.3 and 1.6 versus 1.0). When comparing health education alone to the control, approximately four index patients would need to be offered the intervention to elicit one extra partner (NNT=4.2; 95% CI=2.6 to 10). When comparing health education combined with counselling to the control, approximately two index patients would need to be given the intervention for one extra partner to be elicited (NNT=1.7; 95% CI=1.3 to 2.3). The combination of health education and patientcentred counselling signi® cantly increased the number of partners treated from 0.18 to 0.25 per index patient (NNT=14.3; 95% CI=7.7 to 100). Neither health education nor counselling in isolation increased the number of partners receiving treatment.
General comments
Partner elicitation rates per index patient ranged from 0.7 to 6.9 across all the trials comparing provider, contract and patient referral strategies (Table 1) . Across studies comparing various strategies to improve patient referral, the rate of partner elicitation per index patient ranged from 0.8 to 3.3. The rates of partners who tested positive per index patient ranged from 0.03 to 0.75 across the trials comparing provider contract and patient referral strategies, and from 0.03 to 0.27 across the trial comparing various patient referral strategies (Table 1) . It is not possible to determine whether the differences in rates across studies is a re¯ection of the different populations studied (differing rates of sex partner change, differing cultures with regard to admitting multiple sex partners, differing transmission rates for different diseases), a re¯ection of differing de® nitions of`current partners' used by health services for the various STDs, or an indicator of differential success of the noti® cation strategies themselves.
Few studies included costs. The differences in costs of partner noti® cation strategies across studies can be attributed in part to variations in costing methodology. All costing studies included direct costs of personnel time and communication, but only one study included overhead costs (rental, and programme management), therefore accounting for higher overall costs 7 . No study included indirect costs. Figures 1, 2 and 3 illustrate graphically the results of the ® ve trials comparing patient referral strategies with either provider referral, a choice between provider referral and patient referral, or contract referral. They show that patient referral strategies were almost consistently (across study and STD) more effective at eliciting partners from index patients. However, this did not translate into practically important bene® ts. Patient referral strategies were consistently less effective at ensuring partners were noti® ed and presented to health services to receive the appropriate medical evaluation and treatment. In addition, patient referral strategies were generally less effective at identifying partners who tested positive for the STD in question.
Figures 4 and 5 each illustrate the result of one study. Figure 4 shows the results of the comparison of contract referral with two provider referral strategies among patients with syphilis. It shows that there were very small differences in the effectiveness of the respective strategies (which, in themselves, did not differ very much), except, inexplicably, when measuring the number of partners elicited. Figure 5 shows the effects of nurse-given health education and/or 20± 30 minutes' counselling by a lay worker, when compared with standard care among patients with any STD. It illustrates that the interventions had small effects, which were statistically signi® cant in the case of health education and health education combined with counselling.
DISCUSSION
Determining the most effective means of partner noti® cation from a systematic review of the literature is challenging. First, despite an extensive literature on partner noti® cation for STDs, few randomized controlled trials have been conducted. Secondly, the methodological weaknesses of studies that met even our quality criteria do not allow rigorous conclusions to be made. In every study, there were threats to the validity of the ® ndings. Thirdly, the variability of study designs even within categories, e.g. provider referral, and the differences in diseases assessed, complicate greatly the identi® cation of strategies that are, or are not, effective. Lastly, although most studies were conducted in the USA, that some studies were performed in other countries, including two in the developing world, raises cultural issues that might well in¯uence results and make comparison among studies hazardous.
Even if one determines the effectiveness of varying means of partner noti® cation, a policy maker cannot decide which means to choose without knowing the relative cost of each option. It does little good, for instance, to know the most effective means if it is unaffordable. Unfortunately, the studies provided few cost data. The study by 296 International Journal of STD & AIDS Volume 13 May 2002 Katz et al. 10 provides the most complete data, and shows that provider referral is the most effective means of referral, but also the most expensive. Among the two patient referral strategies, knowing costs makes choosing the`best' strategy easy Ð the nurse-educator strategy brought more partners to treatment and at a cheaper price than did the DISeducator strategy. But the lack of standardized costing methodology, variation in costs per setting, and cultural variation in acceptability of varying noti® cation strategies make simple adoption of a strategy that worked ef® ciently in one locale hazardous without considering local conditions.
Costs must be determined, however, to guide the local selection of a noti® cation method. Partner noti® cation affects either of two outcomes, i.e. prevention of morbidity in those noti® ed, or prevention of transmission to others Ð both are bene® ts. Whether it is better to identify and treat partners who have detectable infection, as opposed to those who have no detectable infection, is arguable. However, it would seem more likely that infected partners are more valuable to identify, since these individuals have either acquired infection from the index case (and are at high risk of further morbidity or transmitting infection to others), or infected the index case (proving that they are high-risk sex partners, responsible for transmission). Few of the studies assessed the proportion of partners who were infected. Instead, most studies relied on surrogate outcomes such as partners presenting for medical evaluation, or reports by index patients of partners presenting. As a result, we cannot know more fully the bene® ts of partner noti® cation.
There are also potential harms to partner noti® cation. These have, however, been poorly investigated in either the studies included in our review or in other studies. Only two of the studies reviewed here investigated the harms resulting from the various partner noti® cation strategies and one has not reported results 5 . Faxelid et al. 4 reported that 27% of STD-positive men in Lusaka, given a choice between patient and provider referral, counselling and contact cards, reported domestic quarrels versus 11% of men performing patient referral only; no differences occurred among STD-positive women given the same choice (11% in both groups). In a pilot project for the Ellison study, provider referral was not an acceptable strategy in their South African site. Although prior to the noti® cation process, 25% of women preferred provider referral compared to patient referral, as did only 2% of men, provider referral was labour intensive and successful in reaching only 11 of 83 (13%) partners sought 15 . One concern was that some patients feared partner noti® cation might lead to violence. However, in the subsequent study, which included only patient referral, no violence was reported 6 . Descriptive studies conducted among index patients with HIV infection in industrialized countries have found very low rates of disclosure of HIV status to sex partners 16 even after repeated counselling of index patients about disclosure and a six-month opportunity to disclose 17 . The reluctance to notify partners suggests expectation of harms from doing so. These harms need further investigation.
Provider versus contract versus patient referral versus choice
There is no strong or consistent evidence for the relative effects of provider, contract, or patient referral, or patient choice among strategies. Provider referral, where the identity of the index patient is not revealed to the partner, is preferred by many index patients, particularly for HIV partner noti®cation 5 . Patient referral incurs less service costs, and in some circumstances may be more effective.
In the light of the absence of compelling evidence, perhaps offering patients a choice is most appropriate and, based on some evidence, it may be most effective 4, 14 . However, it may not be without risks 4 .
Patient education and counselling and provider training
Patient education and counselling, and providertraining are likely to be important strategies to improve partner noti® cation and prevent domestic violence. However, there is no clear evidence to guide decisions about the provision of effective patient education and counselling, and providertraining. We found no studies evaluating providertraining. Of the four studies investigating various health education and counselling strategies, one evaluating an audiovisual presentation was unable to provide suf® cient evidence due to methodological weaknesses 13 . Another evaluating an educational pamphlet failed to demonstrate any effect. A third 6 found that verbal health education together with intense, patient-centred counselling resulted in a small but signi® cant increase in the rate of partners treated. A fourth 4 , which evaluated the effect of counselling and contact cards together with a choice between provider and patient referral, only demonstrated an effect on index patients reports that their partners visited a health facility. Innovative strategies combining provider training and patient education that are based on an evaluation of the barriers to achieving the desired behavioural changes, need to be evaluated. Such interventions may have only moderate effects and evaluation designs need to be rigorous to protect against biases that can be as large or larger than the expected effects.
HIV/AIDS
Only two studies evaluated partner noti® cation strategies for HIV/AIDS 5, 14 . Based on these two studies, there is evidence that giving index patients a choice between provider and patient referral may be more effective than patient referral and this is supported from one other study from a developing country, which included all STDs 4 . However, HIV partner noti® cation interventions require special consideration.
One of the aims of such interventions needs to be long-term behavioural change, and thus interventions may need to include appropriate, long-term support for such change. Other aims are the availability of effective treatments, such as those preventing vertical transmission. Evaluations of HIV partner noti® cation strategies need to address these issues, as well potential harmful effects, such as domestic violence, and costs to ensure that partner noti® cation does more good than harm and that scarce resources are used ef® ciently.
Developing countries
Only two studies were conducted in developing countries 4, 6 . Rigorous evaluations here are even more important than in wealthier countries, to ensure that scarce resources are used effectively and ef® ciently. This requires collaboration between stakeholders and researchers. On the one hand, policy makers, health service providers and consumer groups need to be involved in the evaluations to ensure they are policy-relevant and likely to be implemented. On the other hand, researchers need to help to ensure that evaluations that are undertaken are likely to yield results that are valid as well as relevant. Given the severe limitations of resources and trained health care professionals in developing countries, a particularly important question to investigate is the use of lay health workers 5, 6 .
CONCLUSIONS
The main ® ndings of this review are that there is moderately strong evidence that:
1. Provider referral alone, or the choice between patient and provider referral, when compared with patient referral among patients with HIV or any STD, increases the rate of partners presenting for medical evaluation 4,10,14 . 2. Contract referral, when compared with patient referral among patients with gonorrhoea, results in more partners presenting for medical evaluation 11,12 . 3. Verbal, nurse-given health education together with patient-centred counselling by lay workers, when compared with standard care among patients with any STD, results in small increases in the rate of partners treated 6 .
There is a need for evaluations of interventions combining provider training and patient education, and for evaluations conducted in developing countries. Trials conducted in the future need to assess whether the partner noti® cation strategies they evaluate have an impact on index patient reinfection rates, changes in the behaviour of index patients or partners, particularly for HIV patients, and incidence of STDs. Furthermore, they need to consider measuring to what extent strategies are successful at reaching partners who are`high transmitters' as opposed to monogamous partners. The acceptability of various partner noti® cation strategies to index patients and partners needs to be assessed, and the costs and potential harms of partner noti® cation need to be measured and compared.
